IC, Director CCL, PERT & Structural Heart, Chair NCVH Tampa Bay, #WashU #CLIFighters #ALILovers #ProScience - COI- I consult for everyone/Equally conflicted
Florida, USA
Joined May 2018
- Tweets6.7K
- Following296
- Followers3.9K
- Likes10K
Jay Mathews MD, MS, FACC, FSCAI retweeted
Fewer repeat interventions and less frequent adverse limb events: three studies presented at #VIVA2026 add support for sirolimus-coated balloons in lower-extremity PAD, including patients with CLTI. bit.ly/4hGfd67 @sahilparikhmd @JayMathewsMD
Jay Mathews MD, MS, FACC, FSCAI retweeted
Proud to see the results of the TRUST pivotal study presented at #VIVA26
TRUST enrolled 107 patients across 17 centers and met both its primary safety and effectiveness endpoints. Treatment with the Innova Vascular Laguna Thrombectomy System resulted in a 0.53 absolute reduction in RV/LV ratio at 48 hours, with a 0.9% major adverse event rate.
It was a privilege to serve as Global Co-Principal Investigator alongside @JayMathewsMD. Beyond the numbers, what matters most is seeing new technologies translate into rapid clinical improvement for patients with pulmonary embolism.
Grateful to the patients, investigators, steering committee, research teams, and Innova Vascular team (@ShrivastavaSanj et al.) who made TRUST possible.
An important milestone, and more work ahead as we continue to advance the treatment of PE.
#PulmonaryEmbolism #Thrombectomy #PERT #ClinicalResearch
Jay Mathews MD, MS, FACC, FSCAI retweeted
Standing room only this morning at #VIVA26. @JayMathewsMD discusses the SELUTION4SFA trial to kick off the morning’s late-breaking data presentations.
Virtual registration is available. Register here and watch the livestream: viva-foundation.org/register
Jay Mathews MD, MS, FACC, FSCAI retweeted
@JayMathewsMD @em_ccmdoc and @patrickmuckmd closing off our #HighRiskPE session with a lively debate looking at catheter based options vs systemic lytics vs surgical embolectomy in these deteriorating patients #PERT2026
Jay Mathews MD, MS, FACC, FSCAI retweeted
New data. Live at #VIVA2026.
12-month results from the SELUTION4SFA FDA Study will be presented as late-breaking clinical data.
📅 Oct. 5 | 8:10 AM PT
Presented by Principal Investigator @JayMathewsMD
Explore the trial design ahead of the presentation:
tinyurl.com/eycv9568
#CordisGoBeyond #SFA
Jay Mathews MD, MS, FACC, FSCAI retweeted
CMS NTAP Granted for Reflow Medical Spur Peripheral Retrievable Stent System | @reflowmedical
evtoday.com/news/cms-ntap-gr…
Jay Mathews MD, MS, FACC, FSCAI retweeted
TRUST Pivotal Study of Innova Laguna Thrombectomy System Completes Enrollment
evtoday.com/news/trust-pivot…
Jay Mathews MD, MS, FACC, FSCAI retweeted
Big ideas. Live cases. Meaningful conversations. NYEVS 2026 is more than a conference — it’s where the vascular community comes together to learn, collaborate, and drive progress forward.
See you there - register now! nyevs.org
#InterventionalCardiology #Endovascular #CardioX @JayMathewsMD
Jay Mathews MD, MS, FACC, FSCAI retweeted
Live at NCVH 2026 — hands-on with the latest in peripheral intervention.
We’re showcasing the new **Crosslead Tracker and Penetration wires** (excellent tracking in tortuosity, controlled cap engagement, and strong device support).
Highlight of the week: Our official Asahi Intecc Lunch Symposium “It’s Time! Transforming PAD and CLTI Care from Top to Toe”
📍 Wednesday, May 27 • 12:00 – 1:00 PM
📍 Waldorf Ballroom
Host: Dr. Craig Walker
Keynote Speaker: Mr. Masahiko Miyata (Chairman & Founder, Asahi Intecc)
Speakers: Dr. Ashwani Sastry, Dr. Jay Mathews, Dr. Osama Ibrahim
Fellows, attendings, and lab teams — what PAD/CLTI topics do you hope they cover? Drop your thoughts or questions below 👇
#NCVH2026 #Crosslead #AsahiMedEd #PeripheralIntervention #CLTI #PAD #MedEd
Jay Mathews MD, MS, FACC, FSCAI retweeted
Celebrating an extraordinary career—congratulations to Kenneth Rosenfield, MD, MHCDS, MSCAI, recipient of the Helping Hearts Lifetime Service Award at #SCAI2026 🎉👏
A past SCAI President, his leadership, innovation, and lasting contributions have helped shape vascular and interventional medicine and improve patient care worldwide.
@SrihariNaiduMD @sahilparikhmd
Jay Mathews MD, MS, FACC, FSCAI retweeted
Congratulations to Dr. Yves Louvard & Dr. Jay Mathews on receiving the Annual ARCH Foundation Award!
We are lucky to have their expert insights at #ARCH2026!
#InterventionalCardiology #CardioTwitter #ARCHSymposium #Cardiologist
Jay Mathews MD, MS, FACC, FSCAI retweeted
It is feasible to fracture mechanical valve leaflets using commercially available angioplasty balloons. Cracking the carbon ring requires substantially higher pressure.
Get the details: jacc.org/doi/10.1016/j.jcin.… #JACCINT
Jay Mathews MD, MS, FACC, FSCAI retweeted
It is with heavy hearts that we inform you of the passing of our colleague, friend, and Past President of the Society for Vascular Medicine, Dr. Ido Weinberg.
Read more about Dr. Weinberg's life and legacy here: buff.ly/q9uPGdv
Jay Mathews MD, MS, FACC, FSCAI retweeted
That’s a wrap for the inaugural @clotsheadtotoe ! It was amazing to participate & witness multidisciplinary conversations around thrombus management #headtotoe! What a stellar faculty at the one & only conference focused solely on CLOTS & that too at the happiest place on Earth!
Jay Mathews MD, MS, FACC, FSCAI retweeted
The NCD is now re-opened for TAVR.
"We are particularly interested in comments that include scientific evidence, specifically any peer-reviewed literature, that describes the role of TAVR for AS." cms.gov/medicare-coverage-da…
Coverage with evidence development- is this still needed?
ajmc.com/view/coverage-with-…
Jay Mathews MD, MS, FACC, FSCAI retweeted
DIY Confianza Pro ST – Boost Penetration Power for Your CP12
Here’s how you can achieve this enhancement using a Rotablator:
1. Take an introducer needle and place the CP12 alongside a Rota wire.
2. Sharpen the tip of the CP12 against the rotating burr (1.75mm) of the Rotablator.
Jay Mathews MD, MS, FACC, FSCAI retweeted
Wanted to Invite everyone to join us at ISET 2026 in Miami Beach Feb 9-12. ISET Week . Great speakers, program, live cases without the cold!
#IRAD @vascularSVS @SIRspecialists @SIR_ECS @SIRRFS
Jay Mathews MD, MS, FACC, FSCAI retweeted
Thank you VIVA and honored to present our late breaking abstract, STORM-PE 90 days results showing earlier physiological recovery and improvement in 90 day functional status with MT + AC vs AC alone in intermediate high risk PE pts. Thank you Circ for simultaneous publication. #VIVA2025 @PERTConsortium
#VIVA25: Rachel Rosovsky outlines further results from the STORM-PE RCT with findings simultaneously published in @CircAHA @VIVAPhysicians
Jay Mathews MD, MS, FACC, FSCAI retweeted
STORM-PE shows improved functional outcomes for mechanical thrombectomy at discharge and at 90 days @VIVAPhysicians #VIVA25
⭐️Breaking news from #VIVA25: STORM-PE trial data presented today simultaneously published in Circulation. @CircAHA @AHAScience
We’re excited to see these groundbreaking findings recognized in one of the field’s leading journals.
Read the publication: ahajournals.org/doi/abs/10.1…
Jay Mathews MD, MS, FACC, FSCAI retweeted
Off to a hot start. Standing room only #BlueSky Breakfast highlighting new technologies coming to the venous space #TheVEINS2025 #VIVA25 @VIVAPhysicians
